MedPro's blood collection safety products receive BSI CE Mark approval

MedPro Safety Products, Inc. (OTCBB:MPSP), a leading developer of transformational technologies that enable safer medication delivery and blood collection, today announced that it has received a CE Mark from the British Standards Institute (BSI) for its blood collection safety products. The CE Mark allows the free movement of products throughout the European Union. Products currently covered under the certificate include the VACUETTE® PREMIUM Safety Needle System Tube-Touch, among others.

"The CE Mark is another important milestone for MedPro, allowing for the expansion of sales of the VACUETTE® blood collection devices into large and growing markets in Europe," said Craig Turner, Chairman and CEO of MedPro Safety Products. "We believe our patented passive needlestick technology is a compelling feature that will be well received by healthcare professionals in Europe as it has been in the United States. The CE Mark, along with the 510(K) clearance that we received from the Food and Drug Administration (FDA) last year, has positioned us well to grow our presence globally."

The World Health Organization (WHO) estimates that worldwide, approximately three million healthcare employees, roughly 10% of the global industry's workforce, are exposed to bloodborne pathogens as a result of a needlestick injury each year.

MedPro Safety's devices are based on patented technology that offers healthcare professionals the safety of sample collection through a truly passive needlestick prevention feature that automatically activates through normal use, without the requirement of any additional step by the user. The VACUETTE® PREMIUM Safety Needle System Tube-Touch is equipped with a shield that automatically covers the needle during the blood collection process.